FibroBiologics Announces Patent Application Filing For Fibroblast Methods To Enhance Mitochondrial Performance; 160+ Patents Issued And Pending

BenzingaMar 4 08:34 ET

FibroBiologics Completes Master Cell Bank for CYWC628 in Collaboration With Charles River Laboratories

Quiver QuantitativeFeb 27 08:41 ET

Express News | Fibrobiologics and Charles River Announce Completion and Release of Cywc628 Master Cell Bank for the Manufacturing of Fibroblast Cell-Based Wound Healing Therapeutic

ReutersFeb 27 08:30 ET

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

GlobeNewswireFeb 27 08:30 ET

Express News | Watching FibroBiologics; Zacks Small-Cap Research Gives Stock $11 Price Valuation

BenzingaFeb 24 12:32 ET

FibroBiologics Price Target Maintained With a $16.00/Share by D. Boral Capital

Dow JonesFeb 13 13:10 ET · Ratings